BioCryst Pharmaceuticals, Inc.【BCRX】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 2011/12 2012/12 2013/12 2014/12 2015/12 2016/12 2017/12 2018/12 2019/12 2020/12 2021/12 2022/12 2023/12 2024/12
売上高 19,643 26,293 17,331 13,608 48,257 26,353 25,186 20,653 48,835 17,812 157,170 270,827 331,412 450,712
売上成長率(%) - -63.5 782.4 72.3 22.4 36
売上原価 - - - 1 1,368 2,297 1,142 - 3,726 1,550 7,229 6,408 4,481 12,269
研究開発費 56,898 51,464 42,730 51,796 72,758 61,008 66,962 84,888 107,068 122,964 208,808 253,297 216,566 174,638
販売管理費 - - - - 13,047 11,253 13,933 29,514 37,121 67,929 118,818 159,371 213,894 266,132
営業費用 69,230 60,181 48,048 59,379 87,701 74,960 82,597 114,873 148,290 192,569 334,890 419,262 435,121 453,255
営業利益 -49,587 -33,888 -30,717 -45,771 -39,444 -48,607 -57,411 -94,220 -99,455 -174,757 -177,720 -148,435 -103,709 -2,543
営業利益率 (%) -981.1 -113.1 -54.8 -31.3 -0.6
経常(税引前)利益 - - - - - - - - - - -181,809 -244,383 -226,229 -86,954
経常(税引前)利益率(%) - - - - - - - - - - -115.7 -90.2 -68.3 -19.3
法人税等合計 - - - - - - - - - - 2,253 2,733 310 1,927
実効税率(%) - - - - - - - - - - -1.2 -1.1 -0.1 -2.2
純利益 -56,948 -39,081 -30,108 -45,189 -43,019 -55,144 -65,782 -101,252 -108,897 -182,814 -184,062 -247,116 -226,539 -88,881
純利益率(%) -1026.4 -117.1 -91.2 -68.4 -19.7
一株あたり利益 - - - - - - - - - - - -1.33 -1.18 -0.43
希薄化後一株あたり利益 - - - - - - - - - - - -1.33 -1.18 -0.43
EBITDA - -174,009 -176,943 -146,998 -102,054 -1,297
EBITDAマージン(%) - -976.9 -112.6 -54.3 -30.8 -0.3